Australia invests $537 B in healthcare over next four years

The Coalition Government in Australia is investing in a stronger health system as part of its plan for a stronger future...

March 30, 2022 | Wednesday | News
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix

Australia-based Telix Pharmaceuticals has signed an exclusive agreement with Xiel Limited (Xiel) for the distributi...

March 29, 2022 | Tuesday | News
Telix granted FDA Orphan Drug Designation for bone marrow conditioning treatment

Australia's Telix Pharmaceuticals announced that the United States Food and Drug Administration (FDA) has granted Orphan...

March 29, 2022 | Tuesday | News
Australia explores changes in brain under influence of psychedelic drugs

It is well known that ingesting psilocybin (magic mushrooms) will induce profound changes in consciousness and perceptio...

March 29, 2022 | Tuesday | News
ResApp announces positive results for new novel smartphone-based COVID-19 screening test

ResApp Health, a leading digital health company developing smartphone applications for the diagnosis and management of r...

March 28, 2022 | Monday | News
Australia commences recruitment for Ph 1 trial of two indigenous COVID-19 vaccines

Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...

March 28, 2022 | Monday | News
Critical cystic fibrosis drug now on PBS

Australians with cystic fibrosis will soon have access to a new treatment following the listing of Trikafta® on the ...

March 28, 2022 | Monday | News
Australia invests more than $100 M for seasonal influenza vaccines

The Australian government is investing more than $100 million for seasonal influenza vaccines to protect Aus...

March 25, 2022 | Friday | News
New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer

Australia's Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company developing next-generation products to...

March 25, 2022 | Friday | News
Australia to manufacture mRNA vaccines against future pandemics

An in-principle agreement was first announced in December last year for a factory to produce 25 million doses a year fro...

March 24, 2022 | Thursday | News
CTT Pharma announces Australia patent approval

CTT Pharmaceutical Holdings has expanded its reach into additional international markets with a successful patent applic...

March 24, 2022 | Thursday | News
Australia's first human study into effects of live biotherapeutics on insomnia

Servatus Ltd, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, has ...

March 23, 2022 | Wednesday | News
Telix advances development of Glioblastoma Therapy Program

Telix Pharmaceuticals announces it has made significant progress in advancing the Company's glioblastoma multiforme (GBM...

March 23, 2022 | Wednesday | News
Australia invests $28.1 M to establish new Genomics agency

Through its 10-year Medical Research Future Fund (MRFF) plan, the Australian government is helping Australians live long...

March 22, 2022 | Tuesday | News
Detecting COVID-19 using only a smartphone

ResApp Health announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a ...

March 22, 2022 | Tuesday | News
Australia invests $43 million to expand mental health services

More than $43 million will be invested into mental health and suicide prevention support and services across the Norther...

March 21, 2022 | Monday | News
Australia suggests new therapy to stabilise plaques associated with heart attack

A novel new therapy has been found to reduce harmful plaque in arteries and change its composition so it is less likely ...

March 21, 2022 | Monday | News
Australia registers first eye drops to slow short-sightedness progress in children

Australia-based Aspen Pharmacare has announced the Therapeutic Goods Administration (TGA) listing of a new medicati...

March 18, 2022 | Friday | News